Compositions and methods for treating retinal degradation Grant US-11717520-B2 United States of America 08 Aug 2023
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives Grant US-11618751-B1 United States of America 04 Apr 2023
DIACEREIN OR ITS ANALOGS FOR INHIBITING EXPRESSION OF ASC, NLRP3, AND/OR FORMATION OF… Application EP-4147694-A1 European Patent Office 15 Mar 2023
Compositions and methods for treating retinal degradation Grant US-11602535-B2 United States of America 14 Mar 2023
Sulphonyl urea derivatives as NLRP3 inflammasome modulators Grant US-11518757-B2 United States of America 06 Dec 2022
Inflammasome activation in myelodysplastic syndromes Grant US-11280787-B2 United States of America 22 Mar 2022
Inflammasome inhibition for the treatment of Parkinson's disease, Alzheimer's disease and… Grant US-11219623-B2 United States of America 11 Jan 2022
Sulfonylureas and related compounds and use of same Grant US-11130731-B2 United States of America 28 Sep 2021
Compositions and methods for treating retinal degradation Grant US-10864212-B2 United States of America 15 Dec 2020
Sulfonylureas and related compounds and use of same Grant US-10538487-B2 United States of America 21 Jan 2020
Inflammasome activation in myelodysplastic syndromes Application US-10488411-B2 United States of America 26 Nov 2019
SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS Application WO-2019121691-A1 World Intellectual Property Organisation (WIPO) 27 Jun 2019
DIACEREIN OR ITS ANALOGS FOR INHIBITING EXPRESSION OF ASC, NLRP3, AND/OR FORMATION OF… Application EP-3337782-A4 European Patent Office 03 Apr 2019
Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3… Application US-10195170-B2 United States of America 05 Feb 2019